Director for Signature Research Programme in Cancer and Stem Cell Biology, DukeNUS Medical School &

DukeNUS Medical School is a landmark collaboration between two world-leading institutions of higher education and research – Duke University and National University of Singapore. As a graduate-entry medical school (home to circa 500 students from 32 countries and 3,600 full-time and adjunct faculty and staff), DukeNUS attracts the brightest minds from a range of backgrounds, who bring with them significant academic and life experiences. Along with innovative educational programmes, DukeNUS is a research powerhouse whose distinguished scientists are transforming the way we understand, diagnose and treat diseases. DukeNUS Medical School benefits greatly from its strategic partnership with Singapore Health Services (SingHealth), which includes the National Cancer Centre of Singapore (NCCS).

The faculties of the Signature Research Programme in Cancer and Stem Cell Biology (CSCB) at DukeNUS focus on elucidating fundamental mechanisms of cancer, translating basic science discoveries from bench to bedside through active drug discovery initiatives and innovative clinical trials, with a mission to conduct world-class research and training in cancer and stem cell biology. As a member institute of Singapore Health Services (SingHealth), the National Cancer Centre of Singapore (NCCS) is a global leading cancer centre, with a mission to offer patients hope of a cancer-free tomorrow, by having the best people, providing the best care, doing the best research and leading cancer education.

Through a strategic partnership between DukeNUS Medical School and SingHealth, we are seeking an individual with exceptional scientific credentials and leadership skills to be the Director of the CSCB Programme as well as the Deputy Chief Executive Officer (Research) at NCCS. In addition to being an international leader in cancer and stem cell biology, the successful candidate will be able to demonstrate their ability of growing, leading and mentoring faculty as well as developing and operationalising strategy. Importantly, the next Director will have an outstanding track record relevant to the challenge of navigating and shaping the strategic direction and coordination for cancer research across the SingHealth and DukeNUS Academic Medical Centre and across the basic, translational and clinic research areas present in the partnership.

For more information, including how to apply, please visit https://candidates.perrettlaver.com/vacancies/, quoting reference 7493 or initial inquiries may be directed to Perrett Laver at cscb@perrettlaver.com

The deadline for applications is 30^th September 2024.